1. Home
  2. EXLS vs RGEN Comparison

EXLS vs RGEN Comparison

Compare EXLS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ExlService Holdings Inc.

EXLS

ExlService Holdings Inc.

HOLD

Current Price

$43.22

Market Cap

6.9B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$165.56

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXLS
RGEN
Founded
1999
1981
Country
United States
United States
Employees
59500
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
8.2B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
EXLS
RGEN
Price
$43.22
$165.56
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$54.50
$174.90
AVG Volume (30 Days)
1.1M
618.1K
Earning Date
10-28-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
29.94
N/A
EPS
1.48
0.03
Revenue
$2,026,490,000.00
$707,890,000.00
Revenue This Year
$15.32
$17.84
Revenue Next Year
$11.27
$12.44
P/E Ratio
$29.26
$5,383.25
Revenue Growth
14.43
11.74
52 Week Low
$37.30
$102.97
52 Week High
$52.43
$182.52

Technical Indicators

Market Signals
Indicator
EXLS
RGEN
Relative Strength Index (RSI) 70.43 57.69
Support Level $43.13 $156.01
Resistance Level $43.59 $167.74
Average True Range (ATR) 0.67 4.27
MACD 0.23 0.04
Stochastic Oscillator 83.91 81.59

Price Performance

Historical Comparison
EXLS
RGEN

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: